Breaking News
Monday , July 24 2017
Home / Business / Glenmark receives tentative ANDA approval for generic Vesicare Tablets

Glenmark receives tentative ANDA approval for generic Vesicare Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Solifenacin Succinate Tablets, 5 mg and 10 mg, the generic version of Vesicare Tablets, 5 mg and 10 mg of Astellas Pharma US Inc.

According to IMS Health sales data for the 12 month period ending April 2017, the Vesicare Tablets, 5 mg and 10 mg market achieved annual sales of approximately $1.1 billion.

Loading...

About editor